Mumps Antibodies, IgM
Also known as: Parotitis Epidemica Antibodies
Use
Aid in the diagnosis of acute mumps infection
Special Instructions
The test requires collection of serum in a red-top tube or gel-barrier tube. It is important to ensure that samples are not hemolyzed, lipemic, or contaminated, as these conditions lead to rejection. The test's results need to be interpreted in conjunction with the patient's clinical history and exposure risk.
Limitations
This test is specific to the detection of mumps IgM antibodies and should not be used as a sole diagnostic tool. The presence of IgM antibodies may not be detectable in all patients infected with the mumps virus, particularly in immunocompromised individuals. False positives may occur due to cross-reactivity with other viral infections. It is essential to confirm results with the patient's clinical presentation and possibly additional diagnostic methods.
Methodology
Immunoassay (EIA)
Biomarkers
LOINC Codes
- 25419-3
- 25419-3
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Room temperature
Causes for Rejection
Hemolysis; lipemia; gross bacterial contamination
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |